The five-year survival rate for non-Hodgkin’s lymphoma can be about 70% with early aggressive treatment, while the survival rate for intermediate and advanced stages is not as good as early stages, depending on the individual. Non-Hodgkin’s lymphoma is a group of lymphomas with different histologic features and sites of origin, and is prone to early distant spread. Non-Hodgkin’s lymphomas have many characteristics such as systemic, diverse, and increased incidence with age. Non-Hodgkin’s lymphoma is a malignant tumor with high degree of malignancy. Early stage non-Hodgkin’s lymphoma, if detected and treated early, most of the patients have a better outcome, and the five-year survival rate can be up to about 70%. The effect of middle and late stage patients is worse, and the main purpose is to control the disease, reduce the symptoms and prolong the life. In daily life, family members and patients must maintain a good mindset, do a good job in daily care, actively cooperate with doctors, and undergo regular review to strive for early recovery.